StemCells Inc.'s stock jumped nearly 21 percent Tuesday, after the Newark company said two of three patients with the worst kind of spinal cord injuries continued to show "considerable gains" in feelings a year after receiving an experimental stem cell treatment.
http://www.bizjournals.com/sanfrancisco/blog/biotech/2013/02/stemcells-stem-cells-spinal-cord-injury.html?ana=RSS&s=article_search&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+bizj_national+%28Bizjournals+National+Feed%29
http://www.bizjournals.com/sanfrancisco/blog/biotech/2013/02/stemcells-stem-cells-spinal-cord-injury.html?ana=RSS&s=article_search&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+bizj_national+%28Bizjournals+National+Feed%29
No comments:
Post a Comment